ARTICLE | Top Story
Phase III sepsis data for Lilly's Zovant
January 4, 2001 8:00 AM UTC
Eli Lilly (LLY) said its Phase III PROWESS trial of Zovant recombinant human activated protein C in severe sepsis showing a significant reduction in all-cause mortality compared to placebo at 28 days....